Search Results - "Evers, Melvin M."
-
1
AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington’s Disease Minipig Model
Published in Molecular therapy (05-09-2018)“…Huntington’s disease (HD) is a fatal neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the huntingtin gene. Previously, we showed…”
Get full text
Journal Article -
2
Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy
Published in Molecular therapy. Nucleic acids (07-06-2019)“…A hexanucleotide GGGGCC expansion in intron 1 of chromosome 9 open reading frame 72 (C9orf72) gene is the most frequent cause of amyotrophic lateral sclerosis…”
Get full text
Journal Article -
3
Human Brain Organoids as Models for Central Nervous System Viral Infection
Published in Viruses (18-03-2022)“…Pathogenesis of viral infections of the central nervous system (CNS) is poorly understood, and this is partly due to the limitations of currently used…”
Get full text
Journal Article -
4
A Perspective on Organoids for Virology Research
Published in Viruses (23-11-2020)“…Animal models and cell lines are invaluable for virology research and host-pathogen interaction studies. However, it is increasingly evident that these models…”
Get full text
Journal Article -
5
Artificial MicroRNAs Targeting C9orf72 Can Reduce Accumulation of Intra-nuclear Transcripts in ALS and FTD Patients
Published in Molecular therapy. Nucleic acids (01-03-2019)“…The most common pathogenic mutation in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is an intronic GGGGCC (G4C2) repeat in the…”
Get full text
Journal Article -
6
AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models
Published in Molecular therapy. Methods & clinical development (14-06-2019)“…Huntington disease (HD) is a fatal neurodegenerative disorder caused by an autosomal dominant CAG repeat expansion in the huntingtin (HTT) gene. The translated…”
Get full text
Journal Article -
7
AAV5-miHTT Lowers Huntingtin mRNA and Protein without Off-Target Effects in Patient-Derived Neuronal Cultures and Astrocytes
Published in Molecular therapy. Methods & clinical development (13-12-2019)“…Huntington disease (HD) is a fatal neurodegenerative genetic disorder, thought to reflect a toxic gain of function in huntingtin (Htt) protein…”
Get full text
Journal Article -
8
Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: Removal of the CAG containing exon
Published in Neurobiology of disease (01-10-2013)“…Abstract Spinocerebellar ataxia type 3 is caused by a polyglutamine expansion in the ataxin-3 protein, resulting in gain of toxic function of the mutant…”
Get full text
Journal Article -
9
Targeting several CAG expansion diseases by a single antisense oligonucleotide
Published in PloS one (01-09-2011)“…To date there are 9 known diseases caused by an expanded polyglutamine repeat, with the most prevalent being Huntington's disease. Huntington's disease is a…”
Get full text
Journal Article -
10
Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model
Published in Molecular neurodegeneration (22-06-2018)“…Spinocerebellar ataxia type 3 (SCA3) is a progressive neurodegenerative disorder caused by expansion of the polyglutamine repeat in the ataxin-3 protein…”
Get full text
Journal Article -
11
Enterovirus D68 Infection in Human Primary Airway and Brain Organoids: No Additional Role for Heparan Sulfate Binding for Neurotropism
Published in Microbiology spectrum (26-10-2022)“…Enterovirus D68 (EV-D68) is an RNA virus that can cause outbreaks of acute flaccid paralysis (AFP), a polio-like disease. Before 2010, EV-D68 was a rare…”
Get full text
Journal Article -
12
Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease
Published in Molecular therapy. Methods & clinical development (13-12-2019)“…Spinocerebellar ataxia type 3 (SCA3), or Machado-Joseph disease (MJD), is a progressive neurodegenerative disorder caused by a CAG expansion in the ATXN3 gene…”
Get full text
Journal Article -
13
Cerebral Organoids: A Human Model for AAV Capsid Selection and Therapeutic Transgene Efficacy in the Brain
Published in Molecular therapy. Methods & clinical development (11-09-2020)“…The development of gene therapies for central nervous system disorders is challenging because it is difficult to translate preclinical data from current…”
Get full text
Journal Article -
14
Intrastriatal Administration of AAV5-miHTT in Non-Human Primates and Rats Is Well Tolerated and Results in miHTT Transgene Expression in Key Areas of Huntington Disease Pathology
Published in Brain sciences (20-01-2021)“…Huntington disease (HD) is a fatal, neurodegenerative genetic disorder with aggregation of mutant Huntingtin protein (mutHTT) in the brain as a key…”
Get full text
Journal Article -
15
Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic
Published in Molecular therapy (04-04-2018)“…The single mutation underlying the fatal neuropathology of Huntington’s disease (HD) is a CAG triplet expansion in exon 1 of the huntingtin (HTT) gene, which…”
Get full text
Journal Article -
16
Potent and sustained huntingtin lowering via AAV5 encoding miRNA preserves striatal volume and cognitive function in a humanized mouse model of Huntington disease
Published in Nucleic acids research (10-01-2020)“…Abstract Huntington disease (HD) is a fatal neurodegenerative disease caused by a pathogenic expansion of a CAG repeat in the huntingtin (HTT) gene. There are…”
Get full text
Journal Article -
17
AAV5-miHTT-mediated huntingtin lowering improves brain health in a Huntington’s disease mouse model
Published in Brain (London, England : 1878) (01-06-2023)“…Abstract Huntingtin (HTT)-lowering therapies show great promise in treating Huntington’s disease. We have developed a microRNA targeting human HTT that is…”
Get full text
Journal Article -
18
Antisense-mediated RNA targeting: versatile and expedient genetic manipulation in the brain
Published in Frontiers in molecular neuroscience (01-01-2011)“…A limiting factor in brain research still is the difficulty to evaluate in vivo the role of the increasing number of proteins implicated in neuronal processes…”
Get full text
Journal Article -
19
Antisense oligonucleotides in therapy for neurodegenerative disorders
Published in Advanced drug delivery reviews (29-06-2015)“…Antisense oligonucleotides are synthetic single stranded strings of nucleic acids that bind to RNA and thereby alter or reduce expression of the target RNA…”
Get full text
Journal Article -
20
Emerging Therapies for Huntington’s Disease – Focus on N-Terminal Huntingtin and Huntingtin Exon 1
Published in Biologics (30-09-2022)“…Huntington's disease is a devastating heritable neurodegenerative disorder that is caused by the presence of a trinucleotide CAG repeat expansion in the…”
Get full text
Journal Article